Therapeutic Advances in Vaccines
Overview
Therapeutic Advances in Vaccines is a scientific journal, published by Sage Publications since 2013 in English. The journal's country of origin is United Kingdom.
Details
Details
Abbr.
Ther Adv Vaccines
Publisher
Sage Publications
Start
2013
End
2017
Frequency
Bimonthly
p-ISSN
2051-0136
e-ISSN
2051-0144
Country
United Kingdom
Language
English
Recent Articles
11.
Wang L, Zhu L, Zhu H
Ther Adv Vaccines
. 2016 Aug;
4(1-2):20-31.
PMID: 27551429
Varicella-zoster virus (VZV) infection causes two distinct clinical conditions. Primary varicella infection results in chickenpox, a contagious rash illness typically seen among children. VZV can reactivate years after the initial...
12.
Chacon-Cruz E, Martinez-Longoria C, Llausas-Magana E, Luevanos-Velazquez A, Vazquez-Narvaez J, Beltran S, et al.
Ther Adv Vaccines
. 2016 Aug;
4(1-2):15-9.
PMID: 27551428
Objectives: Meningococcal meningitis is reported as a rare condition in Mexico. There are no internationally published studies on bacterial causes of meningitis in the country based on active surveillance. This...
13.
Fogel J, Kusz M
Ther Adv Vaccines
. 2016 Aug;
4(1-2):3-14.
PMID: 27551427
Objectives: The only human Lyme disease vaccine of LYMErix was voluntarily removed from the market in the United States in 2002 for a number of reasons. A new human Lyme...
14.
Wiedinger K, Romlein H, Bitsaktsis C
Ther Adv Vaccines
. 2015 Dec;
3(5-6):155-63.
PMID: 26668753
Objectives: Previous studies have demonstrated that intranasal administration of inactivated (fixed) Francisella tularensis (iFt) live vaccine strain (LVS) in conjunction with the mucosal adjuvant, cholera toxin B (CTB), provides full...
15.
Takeyama N, Kiyono H, Yuki Y
Ther Adv Vaccines
. 2015 Dec;
3(5-6):139-54.
PMID: 26668752
It has been about 30 years since the first plant engineering technology was established. Although the concept of plant-based pharmaceuticals or vaccines motivates us to develop practicable commercial products using...
16.
Sridhar S
Ther Adv Vaccines
. 2015 Dec;
3(5-6):125-38.
PMID: 26668751
The ongoing outbreak of Ebola virus disease in West Africa highlighted the lack of a licensed drug or vaccine to combat the disease and has renewed the urgency to develop...
17.
Johnson R, Alvarez-Pasquin M, Bijl M, Franco E, Gaillat J, Clara J, et al.
Ther Adv Vaccines
. 2015 Oct;
3(4):109-20.
PMID: 26478818
Herpes zoster (HZ) is primarily a disease of nerve tissue but the acute and longer-term manifestations require multidisciplinary knowledge and involvement in their management. Complications may be dermatological (e.g. secondary...
18.
Cox M, Izikson R, Post P, Dunkle L
Ther Adv Vaccines
. 2015 Oct;
3(4):97-108.
PMID: 26478817
Flublok is the first recombinant hemagglutinin (HA) vaccine licensed by the US Food and Drugs Administration for the prevention of influenza in adults aged 18 and older. The HA proteins...
19.
Nuccitelli A, Rinaudo C, Maione D
Ther Adv Vaccines
. 2015 Aug;
3(3):76-90.
PMID: 26288735
Group B Streptococcus (GBS) is cause of neonatal invasive diseases as well as of severe infections in the elderly and immune-compromised patients. Despite significant advances in the prevention and treatment...
20.
Ahsan M
Ther Adv Vaccines
. 2015 Aug;
3(3):66-75.
PMID: 26288734
Tuberculosis (Tb) continues to be a dreadful infection worldwide with nearly 1.5 million deaths in 2013. Furthermore multi/extensively drug-resistant Tb (MDR/XDR-Tb) worsens the condition. Recently approved anti-Tb drugs (bedaquiline and...